Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Silodosin (KAD 3213) is an alpha-Adrenergic Blocker. The mechanism of action of silodosin is as an Adrenergic alpha-Antagonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 32.00 | |
10 mg | In stock | $ 52.00 | |
25 mg | In stock | $ 76.00 | |
50 mg | In stock | $ 91.00 | |
100 mg | In stock | $ 108.00 | |
200 mg | In stock | $ 135.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Silodosin (KAD 3213) is an alpha-Adrenergic Blocker. The mechanism of action of silodosin is as an Adrenergic alpha-Antagonist. |
Targets&IC50 | α1D-AR:2 nM (Ki), α1B-AR:21 nM (Ki), α1A-AR:0.036 nM (Ki) |
Synonyms | KAD 3213, KMD 3213 |
Molecular Weight | 495.53 |
Formula | C25H32F3N3O4 |
CAS No. | 160970-54-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 92 mg/mL (185.7 mM)
Ethanol: 92 mg/mL (185.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Silodosin 160970-54-7 GPCR/G Protein Neuroscience Adrenergic Receptor Beta Receptor symptoms KMD3213 Inhibitor inhibit lower cancer prostatic KAD 3213 LUTS tract KAD-3213 benign urinary KMD 3213 hyperplasia KAD3213 BPH KMD-3213 inhibitor